JPRN-UMIN000005032已完成未知
Investigation of biomarkers for predicting effectiveness of treatments for inflammatory bowel diseases - Investigation of biomarkers for predicting effectiveness of treatments for inflammatory bowel diseases
Saitama medical Center, Saitama medical University0 个研究点目标入组 200 人开始时间: 2011年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are not applicable for the treatments of leukocyteapheresis, anti-TNF alpha antibody and tacrolimus Patients who disargee informed consent
研究者
相似试验
已完成
不适用
Investigation of biomarkers for predicting effectiveness of treatments for Crohn's diseases diseaseCrohn's diseaseJPRN-UMIN000002341Osaka University Graduate School of Medicine100
已完成
不适用
Research for biomarkers to predict the effectiveness of zoledronic acid in metastatic bone tumorsPatients with bone metastases newly treated by zoledronic acidJPRN-UMIN000018556agoya University Graduate School and School of Medicine27
已完成
不适用
Research for biomarkers to predict the effectiveness of denosumab in metastatic bone tumorsPatients with bone metastases newly treated by denosumabJPRN-UMIN000019700agoya University Graduate School and School of Medicine40
招募中
Unknown
Exploration of biomarkers to predict the effects of anti TSLP antibody (Tezepelumab) in refractory asthma patients using comprehensive analyses of changes in gene expression in whole blood cellsSevere asthmaJPRN-UMIN000050670Department of Respiratory Medicine, University of Tsukuba50
已完成
不适用
Exploratory study for biomarkers to predict efficacy and toxicity to Sorafenib in patients with advanced hepatocellular carcinomaHepatocellulara carcinomaJPRN-UMIN000008808ational Cancer Center Hospital100